ANDREW BLUMENFELD MD

ANDREW BLUMENFELD MD

BNL HEALTH

HEADACHE & MIGRAINE SPECIALIST

ANDREW BLUMENFELD, MD

Dr. Andrew Blumenfeld is Director of The Headache Center of Southern California, San Diego; and co-Director of The Los Angeles Headache Center. He has offices in San Diego and Los Angeles. He is Board-certified in Neurology by the American Board of Psychiatry and Neurology, and is also certified in Headache Medicine.


Dr. Blumenfeld is a member and fellow of both the American Academy of Neurology and the American Headache Society. He is the founding chair of the American Headache Society section on Interventional Procedures for Headache.


Dr. Blumenfeld is published widely and has over 100 peer review publications. One of his manuscripts was voted the top publication in the Headache journal. His research interests have focused on the use of Botox for migraine. He helped to develop the injection protocol used in the pivotal migraine trials and has injected more patients for this condition than any other provider in the world. He teaches other providers on this procedure nationally and internationally. He has been an active researcher in headache with over 10 issued patents for various treatments.  He consults with numerous pharmaceutical companies involved with medications related to headache disorders, and more details can be found through The Sunshine Act.

MEDICAL EDUCATION

  • St. Andrews College, South Africa 1976-1981
  • First class pass and distinction in Mathematics, 1975
  • University of the Witwatersrand 1976-1981
  • Faculty of Medicine, Johannesburg, South Africa
    Bachelor of Medicine and Surgery (MD equivalent)
  • Johannesburg Hospital, South Africa, 1981-1982
  • Internship, General Surgery Resident, Internal Medicine Resident
  • No. 1 Military Hospital, South Africa, 1983-1984
  • Medical Officer (Full Lieutenant), Department of internal medicine
  • Johannesburg Hospital, South Africa 1985-1986
  • Neurology Resident, Department of Neurology
  • University of Massachusetts Medical School  1986-1989
  • Neurology Resident, Department of Neurology
  • University of Massachusetts Medical School 1989-1990
  • Neurophysiology Fellow: EEG and EMG Fellowship

PUBLISHED JOURNALS

LICENSURE

  • California Medical License Number – A47863 Published Journals

DISCLOSURES

  • Advisory Board: Allergan, Abbvie, Aeon, Alder, Amgen, Axsome, BDSI, Biohaven, Impel, Lundbeck, Lilly, Novartis, Revance, Teva, Theranica, Zoscano
  • Speaker: Allergan, Abbvie, Amgen, Biohaven, Lundbeck, Lilly, Teva, BDSI
    Consultant: Allergan, Abbvie, Alder, Amgen, Biohaven, Lilly, Lundbeck, Novartis, Teva, Theranica
  • Grant Support: Allergan, Amgen
  • Contributing Author: Allergan, Abbvie, Amgen, Novartis, Teva, Lilly, Biohaven
Andrew Blumenfeld MD | BNL Health
HEADACHE & MIGRAINE SPECIALIST

ANDREW BLUMENFELD MD

Dr. Blumenfeld is Director of The Headache Center of Southern California, San Diego; and co-Director of BNL Health. He has offices in San Diego and Los Angeles. He is Board-certified in Neurology by the American Board of Psychiatry and Neurology, and is also certified in Headache Medicine.


Dr. Blumenfeld is a member and fellow of both the American Academy of Neurology and the American Headache Society. He is the founding chair of the American Headache Society section on Interventional Procedures for Headache.


Dr. Blumenfeld is published widely and has over 100 peer review publications. One of his manuscripts was voted the top publication in the Headache journal. His research interests have focused on the use of Botox for migraine. He helped to develop the injection protocol used in the pivotal migraine trials and has injected more patients for this condition than any other provider in the world. He teaches other providers on this procedure nationally and internationally. He has been an active researcher in headache with over 10 issued patents for various treatments.  He consults with numerous pharmaceutical companies involved with medications related to headache disorders, and more details can be found through The Sunshine Act.

MEDICAL EDUCATION

  • St. Andrews College, South Africa 1976-1981
  • First class pass and distinction in Mathematics, 1975
  • University of the Witwatersrand 1976-1981
  • Faculty of Medicine, Johannesburg, South Africa
    Bachelor of Medicine and Surgery (MD equivalent)
  • Johannesburg Hospital, South Africa, 1981-1982
  • Internship, General Surgery Resident, Internal Medicine Resident
  • No. 1 Military Hospital, South Africa, 1983-1984
  • Medical Officer (Full Lieutenant), Department of internal medicine
  • Johannesburg Hospital, South Africa 1985-1986
  • Neurology Resident, Department of Neurology
  • University of Massachusetts Medical School  1986-1989
  • Neurology Resident, Department of Neurology
  • University of Massachusetts Medical School 1989-1990
  • Neurophysiology Fellow: EEG and EMG Fellowship

LICENSURE

  • California Medical License Number – A47863 Published Journals

DISCLOSURES

  • Advisory Board: Allergan, Abbvie, Aeon, Alder, Amgen, Axsome, BDSI, Biohaven, Impel, Lundbeck, Lilly, Novartis, Revance, Teva, Theranica, Zoscano
  • Speaker: Allergan, Abbvie, Amgen, Biohaven, Lundbeck, Lilly, Teva, BDSI
    Consultant: Allergan, Abbvie, Alder, Amgen, Biohaven, Lilly, Lundbeck, Novartis, Teva, Theranica
  • Grant Support: Allergan, Amgen
  • Contributing Author: Allergan, Abbvie, Amgen, Novartis, Teva, Lilly, Biohaven
Share by: